ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for Advanced HER2- GC/GEJC - Outcomes in the Protocol-Specified PD-L1-Selected Populations"

150 views
July 11, 2023
Comments 0
Login to view comments. Click here to Login